Symphony Evolution
As of the edition of 20 October 2026, Symphony Evolution runs 2 drugs; it is on route A at 12 targets and on route B at 0 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Went quiet | 2 |
| Total | 2 |
Where it needs a new molecule
Route A at 12 targets, route B at 0 targets.
All 12 rows on route A or B
In the product12 company-target rows on route A or B; 9 are not shown here, and no score is.
See all 12 targets where Symphony Evolution needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Cancer: 9 trials led
- Pregnancy and women's health: 3 trials led
- Urinary and reproductive: 3 trials led